CIS Biotech, Inc. was formed in 2000, as a Georgia (USA) corporation, building on decades of scientific research in neurobiology and laboratory medicine, and resulting in the patenting of rapid, inexpensive blood tests to detect markers of ischemic attack, or stroke.